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Encephalopathy in a dialysis patient treated with
lanthanum carbonate (LC)
Sir,
Dr Fraile et al. [1] report the interesting case of a dialysis
patient who was treated with lanthanum carbonate (LC;
2000 mg daily for 8 months increased to 3500 mg daily for
the subsequent 10 months) and developed acute confu-
sional syndrome. Conduct disorders and delirious ideas were
also observed. The neurological examination was normal
and the electroencephalogram tracing, as well as brain Com-
puted Tomography scan, was also referred as normal. After
removing LC from therapy, the patient improved in 72 h.
Interestingly, Dr Fraile assessed LC concentration in cer-
ebrospinal fluid (CSF) and in serum and the levels were very
high (33.85 and 49 lg/L, respectively). The LC serum and
CSF levels were measured also 10 weeks after the admit-
tance and were found surprisingly undetectable. Of interest,
the CSF protein levels that was>100mg/dL in two occasions.
The authors speculate on the fact that high-serum levels
of free LC could be a consequence of reduced serum pro-
tein (serum albumin was 2.3 g/dL at admittance) and that
blood–brain barrier (BBB) could be also altered by LC itself
or by pre-existing pathological conditions.
In their final conclusions, the AA are rising the hypoth-
esis that LC might potentially damage and cross and the
BBB thus increasing the risk of neurological side effects in
dialysis patients.
The authors also claim that no brain deposit of LC or
cognitive disorders have been described so far in patients
treated with LC, forgetting, however, the important contri-
bution by Altmann et al. [2] who showed—in a prospective
randomized multicenter study—that cognitive function
deteriorates in haemodialysis patients over a 2-year time
period and that LC, as a phosphate binder, does not ad-
versely affect cognitive function compared with standard
therapy. This study confirms previous studies performed in
animals, exposed to large doses of LC, in which it has been
shown that Lanthanum ions cannot pass between the tight
junctions of the BBB [3]. Moreover, additional contributions
confirmed the safety of LC therapy in dialysed patients
followed for up to 6 years [4].
In sum, it is not surprising that a deranged BBB could
allow a high LC concentration in CSF in this patient. The
real surprise is that this patient also had likely a concom-
itant increased intestinal permeability, combined with a
severe liver cirrhosis, a typical condition in which LC should
never be administered.
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